Project Grant HT94252410009
Award Date
11/15/23
Completion Date
11/14/25
Dollars Obligated
$313K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Lowell, MA 01854, USA
Similar Awards
This $2,131,863 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at the University of Oklahoma Health Sciences Center to investigate expanded GAA-GGA chimeric repeats in Friedreich ataxia. The research aims to transform healthcare for military service members, veterans, and the public by addressing critical health challenges related to this genetic disorder. The 4-year...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $676,117 to The Children's Hospital of Philadelphia Research Institute to conduct research on expanded GAA-GGA chimeric repeats in Friedreich ataxia. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical research to address critical health challenges. The award period runs...
The University of Massachusetts Medical School was awarded a $836,992 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2025, will fund research to investigate the effects of military-associated environmental toxins on motor neurons and glial cells in sporadic amyotrophic lateral sclerosis (ALS). The research aims to transform healthcare for military service members, veterans, and the broader...
The University of Florida (UF) Division of Sponsored Research has been awarded a $2,235,400 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The award, effective April 1, 2024 through March 31, 2028, will support research on the "Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias." This project grant is part of the Military Medical Research and Development program, which...
The U.S. Defense Health Agency awarded a $1,626,932.00 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on March 1, 2025, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the grant will fund the "Detection and Quantification of Early Motor...
This $315,958 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by Rush University Medical Center to investigate the neural underpinnings of the relationship between cognitive and gait dysfunction in Fragile X-associated Tremor/Ataxia Syndrome (FXTAS). The award period runs from September 30, 2024 to September 29, 2026. This research aims to transform health care for...
The University of Massachusetts Lowell, through its Office of Research Administration-Lowell, has been awarded a $176,000 Project Grant by the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The grant, effective March 1, 2024 through February 28, 2026, will fund research to transform health care for U.S. military service members and the American public through innovative and impactful biomedical research on topics relevant to military medicine. The...
This $952,162 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to develop novel, improved adeno-associated virus (AAV) vectors for the treatment of amyotrophic lateral sclerosis (ALS). The award was granted to the University of Massachusetts Medical School (UMass Medical) in Worcester, MA, with a period of performance from August 1, 2025 to July 31, 2027. UMass Medical, as a prominent academic...
This $1,675,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at Yale University aimed at transforming healthcare for military service members, veterans, and the broader public. The research project, titled "Drug Discovery for Dystonia and Frontotemporal Degeneration," will be conducted over a 4-year period from August 2025 to August 2029. The work at Yale University is expected...
The University of Massachusetts was awarded a $153,309 project grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 1, 2024, supports research to extend the period of performance for a project titled "Modeling Spread Through Air Spaces with Lung-on-a-Chip". This research aims to transform healthcare for military service members, veterans, and the broader public through innovative biomedical...